Co-Authors
This is a "connection" page, showing publications co-authored by MIHAIL CHELU and NA LI.
Connection Strength
2.859
-
"Sorting" SERCA2a: A novel therapeutic strategy in heart failure? Int J Cardiol. 2018 12 01; 272:306-307.
Score: 0.646
-
Biomarkers (plasma trimethylamine-N-oxide) to predict atrial fibrillation: Are we there yet? Int J Cardiol. 2018 09 15; 267:116-117.
Score: 0.636
-
Reading Tea Leaves: Epigallocatechin-3-Gallate for Targeting Atrial Fibrosis. Cardiovasc Drugs Ther. 2024 Sep 09.
Score: 0.246
-
Cardiac conduction diseases: understanding the molecular mechanisms to uncover targets for future treatments. Expert Opin Ther Targets. 2024 May; 28(5):385-400.
Score: 0.240
-
Dapagliflozin for Atrial Fibrillation. Cardiovasc Drugs Ther. 2024 Feb; 38(1):1-3.
Score: 0.236
-
Sinus node dysfunction: current understanding and future directions. Am J Physiol Heart Circ Physiol. 2023 03 01; 324(3):H259-H278.
Score: 0.218
-
NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias. Cardiovasc Res. 2021 06 16; 117(7):1746-1759.
Score: 0.196
-
Genetics of atrial fibrillation. Curr Opin Cardiol. 2021 05 01; 36(3):281-287.
Score: 0.195
-
Cardiomyocyte Inflammasome Signaling in Cardiomyopathies and Atrial Fibrillation: Mechanisms and Potential Therapeutic Implications. Front Physiol. 2018; 9:1115.
Score: 0.161
-
Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice. J Clin Invest. 2009 Jul; 119(7):1940-51.
Score: 0.086